Les Echos Patrimoine3 小时
First-In-Human Data about the Treatment of Muscle-Invasive Bladder Cancer with Pentixapharm ...
Pentixapharm presents first-in-human data on Lu177-PentixaTher for Muscle-Invasive Bladder Cancer at ASCO-GU 2025, showing potential for bladder preservation and targeted treatment ...
PharmiWeb3 小时
First-In-Human Data about the Treatment of Muscle-…
ConferenceFirst-In-Human Data about the Treatment of Muscle-Invasive Bladder Cancer with Pentixapharm’s Lu177-PentixaTher to be Presented at ASCO-GU 2025 13.02.2025 / 14:10 CET/CESTThe issuer is ...